| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Women's Issues > Assisted Infertility Technology |
|
E-Articles - Assisted Infertility Technology
If the variety of natural infertility treatment options and medication infertility treatment methods do not According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product work for you, than your doctor may recommend assisted reproductive technology (ART). Infertility treatmen ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in under the assisted reproductive technology heading are methods that involve implanting a fertilized egg in lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. o the female's uterus. There are currently about seven infertility treatment methods that are considered a here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe sisted reproductive technology. Likely to be the most common infertility treatment method is IVF- or In Vi d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ro Fertilization. The female's eggs are extracted and combined with the partner's sperm in a petri dish. ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc If fertilization occurs, the fertilized egg is returned to the uterus. This method of infertility treatmen easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi will often involve fertility drugs to increase the number of eggs the female produces to increase the rate nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically of success. Local anesthetics are often used to make the process as comfortable as possible. Another meth and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ d of assisted reproductive technology is GIFT- or Gamete Intrafallopian Transfer. This particular infertil ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ty treatment method combines the female egg and male sperm in the same manner as IVF, except they are trans ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ferred into the female's fallopian tubes for the fertilization to occur within the body rather than a petri dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod dish. The female must have no abnormal fallopian tube functioning, and will require the use of general anes cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin hesia for the infertility treatment procedure. If the cause of infertility is due to the female being unab tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen e to produce quality eggs for fertilization, than an egg donor can provide a healthy egg for IVF. If succe t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel sful fertilization occurs, the female will give birth to the child biologically, but the child will not hav ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e the genetic make up of the mother. This infertility treatment option usually has a success rate between y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products 0 and 60% of the time. Other assisted reproductive technology exists to help infertile couples give birth. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de The infertility treatment method you choose should be considered carefully and with the help of your docto elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Entrepreneurs: Don’t Sell It - Give It Away! Phizer Cuts Multitude of Drug Sale Representatives by 20%
|